Show simple item record

dc.contributor.authorStöhr, Eric J.
dc.contributor.authorMcDonnell, Barry
dc.date.accessioned2018-10-25T16:13:21Z
dc.date.available2018-10-25T16:13:21Z
dc.date.issued2018-10-01
dc.identifier.urihttp://hdl.handle.net/10369/10150
dc.description.abstractFor the first time in history, some humans live without a palpable pulse (Purohitet al., 2018). This 65remarkable physiology is the consequence of surgical implantation of a continuous-flow left 66ventricular assist device (CF-LVAD) in patients with end-stage heart failure.Blood flow produced 67by CF-LVADs has a low oscillatory profile in the aortathat results insignificantly reduced 68pulsatilityin all arterial compartments(Castagnaet al., 2017, Figure 1A and 1B).Despite 69remarkable gains in quality of life and longevity, complications that affect not only morbidity such 70as gastrointestinal bleeding, but also mortality such as strokes,arestill prevalent inCF-LVAD 71patients. Lowpulsatility has been proposedas a major culprit in contributingto these adverse 72events(Mancini & Colombo, 2015;Goldsteinet al., 2018).In this CrossTalk, we presentthe 73current arguments in favour of maintaining an appropriate amount of arterial pulsatility, in 74particular in the cerebral circulation, to lower risk in these patientsen_US
dc.language.isoenen_US
dc.titleBlood Flow Pulsatility in LVAD Patients is essential to Maintain Normal Brain Physiologyen_US
dc.typeArticleen_US
rioxxterms.versionNAen_US


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record